October 26, 2006
Recently Congressman Henry Waxman (D-CA) has been involved in correspondence with Acting Commissioner Andrew C. von Eschenbach. He wrote on August 23, September 22 and now again on October 23. It seems to be a monthly thing. His concern is … Continue reading →
October 4, 2006
There is perhaps no better candidate in the pipeline for an RX to OTC switch than for statins. Statins lower cholesterol dramatically and therefore one can intuit – they would lower the rate of heart disease in this country if … Continue reading →
June 14, 2006
Apparently now it is being reported by the Minneapolis Star Tribune and Associated Press that Dr. Lester Crawford is stating that there was no attempt to disallow Plan B’s switch from RX to OTC, but rather that he delayed the … Continue reading →
May 30, 2006
Last week, former Acting Commissioner and former Commissioner Lester B. Crawford admitted in a deposition that he acted to pre-empt FDA staff from approving the OTC switch of Plan B, according to a report in the Baltimore Sun. What he … Continue reading →
May 4, 2006
As mentioned yesterday, the increase in the number of patent expirations set for the next few years indicates an opportunity for an increase in RX to OTC switches. In March, I had a posting on the challenges in the current … Continue reading →